Autoimmune heparin-induced thrombocytopenia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:698945
Who is this for?
Show terms as
2Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

FDA & Trial Timeline

2 events
May 2024Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

Hospices Civils de Lyon — NA

TrialACTIVE NOT RECRUITING
Nov 1997

Neumega: FDA approved

Prevention of severe chemotherapy-induced thrombocytopenia.

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Autoimmune heparin-induced thrombocytopenia.

View clinical trials →

No actively recruiting trials found for Autoimmune heparin-induced thrombocytopenia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autoimmune heparin-induced thrombocytopenia community →

Specialists

2 foundView all specialists →
PP
Pr Jérôme Honnorat, Pr
Bron
Specialist

Rare Disease Specialist

JA
John Alexander
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

Neumega

Genetics Institute, Inc.

Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications

Travel Grants

No travel grants are currently matched to Autoimmune heparin-induced thrombocytopenia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autoimmune heparin-induced thrombocytopeniaForum →

No community posts yet. Be the first to share your experience with Autoimmune heparin-induced thrombocytopenia.

Start the conversation →

Latest news about Autoimmune heparin-induced thrombocytopenia

Disease timeline:

New trial: Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

Phase NA trial recruiting. Description of clinical, immunological and tumor features of patients harboring CV2 Abs

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Autoimmune heparin-induced thrombocytopenia

Which specialists treat Autoimmune heparin-induced thrombocytopenia?

2 specialists and care centers treating Autoimmune heparin-induced thrombocytopenia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Autoimmune heparin-induced thrombocytopenia?

1 patient support program are currently tracked on UniteRare for Autoimmune heparin-induced thrombocytopenia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.